Marisa Iborra

Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease

Marisa Iborra, Francesca Bernuzzi, Carmen Correale et al. · Clinical & Experimental Immunology · 2013 · 130 citations · Full text

Medicine, Molecular Medicine, Pathology +17

Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohnʼs disease

Belén Beltrán, Pilar Nos, Marisa Iborra et al. · Inflammatory Bowel Diseases · 2009 · 127 citations

Life Sciences, Cell Biology, Immunology +17

Assessing an Improved Protocol for Plasma microRNA Extraction

Inés Moret, Dolors Sánchez-Izquierdo, Marisa Iborra et al. · PLoS ONE · 2013 · 104 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +15

Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry

María Chaparro, Ana Garre, Elena Ricart et al. · Alimentary Pharmacology & Therapeutics · 2018 · 100 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect

Marisa Iborra, Belén Beltrán, Guillermo Bastida et al. · Journal of Crohn s and Colitis · 2010 · 88 citations · Full text

Medicine, Dermatology, Immunology +16